Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations
By Katabella Roberts The U.S. Department of Health and Human Services (HHS) said on Jan. 17 that it has selected the next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as the federal government seeks to lower soaring medical costs for Americans. The drugs are relied upon by millions of seniors across the country to treat an array of conditions such…
More Stories
Geode Capital Management LLC Grows Position in HealthStream, Inc. (NASDAQ:HSTM)
Geode Capital Management LLC lifted its position in shares of HealthStream, Inc. (NASDAQ:HSTM – Free Report) by 2.9% during the...
Q3 Earnings Estimate for BPMC Issued By Wedbush
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities research analysts at Wedbush issued their Q3 2026 EPS estimates for...
Ubiquiti Inc. (NYSE:UI) Position Boosted by Geode Capital Management LLC
Geode Capital Management LLC raised its holdings in shares of Ubiquiti Inc. (NYSE:UI – Free Report) by 1.2% during the...
Seaport Res Ptn Issues Negative Estimate for SPXC Earnings
SPX Technologies, Inc. (NYSE:SPXC – Free Report) – Equities researchers at Seaport Res Ptn dropped their Q1 2026 EPS estimates...
What is Leerink Partnrs’ Forecast for ABCL Q1 Earnings?
AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS)...
What is DA Davidson’s Estimate for Workday FY2026 Earnings?
Workday, Inc. (NASDAQ:WDAY – Free Report) – Equities researchers at DA Davidson lowered their FY2026 EPS estimates for Workday in...